Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

Clinical trial NCT07129629 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07129629
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberculosis, Pulmonary Drug-Susceptible Pulmonary Tuberculosis

Start date: 2025-08-20
Primary completion: 2026-12-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.